Evidence map›Paper›PMID 38424368›Full record

ArticleInsights into imaging2024

Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study.

Jie Bao, Xiaomeng Qiao, Yang Song, Yueting Su, Libiao Ji, Junkang Shen, Guang Yang, Hailin Shen, Ximing Wang, Chunhong Hu

Abstract read
In one paragraph

Article in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Reproducibility and interpretability in radiomics: a critical assessmentDiagnostic and interventional radiology (Ankara, Turkey) · 2025
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jie BaoDepartment of Radiology, The First Affiliated Hospital of Soochow University, 188#, Shizi Road, Suzhou, Jiangsu, 215006, China.
Xiaomeng QiaoDepartment of Radiology, The First Affiliated Hospital of Soochow University, 188#, Shizi Road, Suzhou, Jiangsu, 215006, China.
Yang SongScientific Marketing, Siemens Healthineers, Shanghai 430#, Linqing Road, Shanghai, 201318, China.
Yueting SuDepartment of Radiology, The People's Hospital of Taizhou, 210#, Yingchun Road, Taizhou, Jiangsu, 225399, China.
Libiao JiDepartment of Radiology, Changshu NO.1 People's Hospital, 1#, Shuyuan Street, Changshu, Jiangsu, 215501, China.
Junkang ShenDepartment of Radiology, The Second Affiliated Hospital of Soochow University, 1055#, Sanxiang Road, Suzhou, Jiangsu, 215004, China.
Guang YangShanghai Key Laboratory of Magnetic Resonance, East China Normal University, 3663#, Zhongshanbei Road, Shanghai, China.
Hailin ShenDepartment of Radiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, 118#, Wanshen Street, Suzhou, Jiangsu, 215028, China. hailinshen@163.com.
Ximing WangDepartment of Radiology, The First Affiliated Hospital of Soochow University, 188#, Shizi Road, Suzhou, Jiangsu, 215006, China. wangximing1998@163.com.
Chunhong HuDepartment of Radiology, The First Affiliated Hospital of Soochow University, 188#, Shizi Road, Suzhou, Jiangsu, 215006, China. sdfyyhch@163.com.

Funding

Gusu health talent project of Suzhou GSWS2020003Special Program for Diagnosis and Treatment Technology of Clinical Key Diseases in Suzhou LCZX202001The Suzhou Science and Technology Development Plan Project KJXW2023006
6 · The paper itself

Abstract

purposeTo develop and evaluate machine learning models based on MRI to predict clinically significant prostate cancer (csPCa) and International Society of Urological Pathology (ISUP) grade group as well as explore the potential value of radiomics models for improving the performance of radiologists for Prostate Imaging Reporting and Data System (PI-RADS) assessment. MATERIAL AND

methodsA total of 1616 patients from 4 tertiary care medical centers were retrospectively enrolled. PI-RADS assessments were performed by junior, senior, and expert-level radiologists. The radiomics models for predicting csPCa were built using 4 machine-learning algorithms. The PI-RADS were adjusted by the radiomics model. The relationship between the Rad-score and ISUP was evaluated by Spearman analysis.

resultsThe radiomics models made using the random forest algorithm yielded areas under the receiver operating characteristic curves (AUCs) of 0.874, 0.876, and 0.893 in an internal testing cohort and external testing cohorts, respectively. The AUC of the adjusted_PI-RADS was improved, and the specificity was improved at a slight sacrifice of sensitivity. The participant-level correlation showed that the Rad-score was positively correlated with ISUP in all testing cohorts (r > 0.600 and p < 0.0001).

conclusionsThis radiomics model resulted as a powerful, non-invasive auxiliary tool for accurately predicting prostate cancer aggressiveness. The radiomics model could reduce unnecessary biopsies and help improve the diagnostic performance of radiologists' PI-RADS. Yet, prospective studies are still needed to validate the radiomics models further. CRITICAL RELEVANCE STATEMENT: The radiomics model with MRI may help to accurately screen out clinically significant prostate cancer, thereby assisting physicians in making individualized treatment plans. KEY POINTS: • The diagnostic performance of the radiomics model using the Random Forest algorithm is comparable to the Prostate Imaging Reporting and Data System (PI-RADS) obtained by radiologists. • The performance of the adjusted Prostate Imaging Reporting and Data System (PI-RADS) was improved, which implied that the radiomics model could be a potential radiological assessment tool. • The radiomics model lowered the percentage of equivocal cases. Moreover, the Rad-scores can be used to characterize prostate cancer aggressiveness.

Indexed as

Neoplasms, Prostatic, Magnetic resonance imaging, Random forest, Retrospective study

Identifiers

PMID38424368
PMCPMC10904705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.